Probiotics and Hospital Outcome in the Elderly (PROAGE)
Primary Purpose
Diarrhea, Constipation
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
VSL#3
placebo
Sponsored by
About this trial
This is an interventional prevention trial for Diarrhea focused on measuring probiotics, elderly, motility, diarrhea
Eligibility Criteria
Inclusion Criteria:
- Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent.
Exclusion Criteria:
- Known or suspected allergy to any probiotics
- Neutropenia
- Inability to sign an informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Probiotics, VSL#3
Placebo
Arm Description
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received commercially available probiotics (VSL#3) for 45 days.
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received placebo sachets for 45 days.
Outcomes
Primary Outcome Measures
Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group
Gastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.
Secondary Outcome Measures
Improvement in Nutritional and Immunological Measurements
Full Information
NCT ID
NCT00794924
First Posted
October 28, 2008
Last Updated
November 19, 2008
Sponsor
Kaplan-Harzfeld Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00794924
Brief Title
Probiotics and Hospital Outcome in the Elderly
Acronym
PROAGE
Official Title
Effects of Commercially Available Probiotics on Hospital Outcome
Study Type
Interventional
2. Study Status
Record Verification Date
November 2008
Overall Recruitment Status
Completed
Study Start Date
February 2004 (undefined)
Primary Completion Date
January 2005 (Actual)
Study Completion Date
January 2005 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Kaplan-Harzfeld Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Probiotics have been shown to reduce the rate of diarrhea and constipation. The purpose of this study was to investigate if probiotics could improve outcome of hospitalized orthopedic elderly patients.
Detailed Description
The patients were divided into two groups. One received probiotics for 45 days and the second received placebo. The patients had a clinical and epidemiological as well as nutritional assessment. They were followed-up as for their bowel movements, abdominal pain and nosocomial infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diarrhea, Constipation
Keywords
probiotics, elderly, motility, diarrhea
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
345 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Probiotics, VSL#3
Arm Type
Experimental
Arm Description
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received commercially available probiotics (VSL#3) for 45 days.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received placebo sachets for 45 days.
Intervention Type
Dietary Supplement
Intervention Name(s)
VSL#3
Other Intervention Name(s)
probiotics, VSL phrma,USA
Intervention Description
one sachet per day, for 45 consecutive days
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Intervention Description
one sachet per day, for 45 consecutive days
Primary Outcome Measure Information:
Title
Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group
Description
Gastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.
Time Frame
45 days of measuring the outcome
Secondary Outcome Measure Information:
Title
Improvement in Nutritional and Immunological Measurements
Time Frame
45 days
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent.
Exclusion Criteria:
Known or suspected allergy to any probiotics
Neutropenia
Inability to sign an informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hilla Zahroni, MA
Organizational Affiliation
Chief dietician
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
21369670
Citation
Zaharoni H, Rimon E, Vardi H, Friger M, Bolotin A, Shahar DR. Probiotics improve bowel movements in hospitalized elderly patients--the PROAGE study. J Nutr Health Aging. 2011 Mar;15(3):215-20. doi: 10.1007/s12603-010-0323-3.
Results Reference
derived
Learn more about this trial
Probiotics and Hospital Outcome in the Elderly
We'll reach out to this number within 24 hrs